Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of a new independent director, Patrick Kennedy, to its Board of Directors. Mr. Kennedy, Chair and Governor of the Bank of Ireland, has been appointed to the Jazz Board and will serve on the Audit Committee effective March 1, 2024. Peter Gray has decided not to seek re-election to the Jazz Board at the next Annual General Meeting, expected in July 2024.
Nuclear bosses have accused the SNP’s energy secretary of spreading “shocking” falsehoods about the industry as the Cop28 summit backed “accelerating” the energy source to reduce the world’s climate emissions.